Last deal

$12M

Amount

Series A

Stage

12.04.2015

Date

2

all rounds

$17.5M

Total amount

date founded

Financing round

General

About Company
Quiet Therapeutics develops targeted cancer drugs using proprietary nanoparticle technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Founded in 2010, Quiet Therapeutics is an emerging biotech company focused on developing cancer drugs. Their unique nanoparticle-based delivery system, called Gagomers, enables them to target cell components that other therapies cannot reach. By specifically targeting tumor cells, their drugs lead to the death of cancer cells, improving the lives of patients.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Alpine Biosciences

Alpine Biosciences

Alpine Biosciences develops nanoparticle-based therapies for cancer and rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Life Science

Location

Seattle, WA, USA
BiVictriX Therapeutics

BiVictriX Therapeutics

BiVictriX Therapeutics is a biotech company developing novel bispecific ADCs to target unmet need in blood cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Alderley Edge SK9, UK

total rounds

2
EnGeneIC

EnGeneIC

EnGeneIC is a bioscience company that develops and commercializes targeted delivery of therapeutic agents directly to cancer cells.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sydney NSW, Australia

total rounds

5

total raised

$16.98M
DLVR Therapeutics

DLVR Therapeutics

DLVR Therapeutics is a biotech company developing a nanoparticle delivery system that targets cancer cells.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Toronto, ON, Canada

total rounds

1

Financials

Funding Rounds
2
2

Number of Funding Rounds

$17.5M

Money Raised

Their latest funding was raised on 12.04.2015. Their latest investor Arkin Holdings. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Jerusalem Global Ventures

Jerusalem Global Ventures

Jerusalem Global Ventures is an Israeli Investment Firm that funds technology startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Venture Capital, Financial Services

Location

Jerusalem, Israel

total rounds

1

total raised

$3M

count Of Investments

27

count Of Exists

15
Arkin Holdings

Arkin Holdings

Arkin Holdings empowers breakthrough healthcare companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Herzliya, Israel

count Of Investments

22

count Of Exists

1
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Arkin Holdings

Arkin Holdings

Arkin Holdings empowers breakthrough healthcare companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Herzliya, Israel

count Of Investments

22

count Of Exists

1
Jerusalem Global Ventures

Jerusalem Global Ventures

Jerusalem Global Ventures is an Israeli Investment Firm that funds technology startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Venture Capital, Financial Services

Location

Jerusalem, Israel

total rounds

1

total raised

$3M

count Of Investments

27

count Of Exists

15

People

Employee Profiles
1

Dan Peer

Founder and Inventor

Activity

Recent News
0